Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes

Description

This study aims to understand the use of continuous glucose monitors (CGM) in Asian Americans with type 2 diabetes (T2D). Researchers will compare participants on continuous glucose monitors with participants using fingerstick self-monitoring with the aim of answering the following questions: 1. Check if continuous glucose monitoring is doable and consistent for this group, and see how it affects their quality of life. 2. Estimate how well the health outcomes (glucose and lipid markers) vary over the study period. 3. Understand how social and community factors can impact the use of continuous glucose monitors in this group.

Conditions

Diabetes Mellitus, Type 2

Talk to us

Study Overview

On this page

Study Details

Study overview

This study aims to understand the use of continuous glucose monitors (CGM) in Asian Americans with type 2 diabetes (T2D). Researchers will compare participants on continuous glucose monitors with participants using fingerstick self-monitoring with the aim of answering the following questions: 1. Check if continuous glucose monitoring is doable and consistent for this group, and see how it affects their quality of life. 2. Estimate how well the health outcomes (glucose and lipid markers) vary over the study period. 3. Understand how social and community factors can impact the use of continuous glucose monitors in this group.

A Pilot Clinical Trial to Assess Feasibility, Facilitators and Barriers of Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes

Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes

Condition
Diabetes Mellitus, Type 2
Intervention / Treatment

-

Contacts and Locations

Boston

Joslin Diabetes Center, Boston, Massachusetts, United States, 02215

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Chinese Americans 40 years and older who are 1st generation immigrants, currently residing in the US, and clinically diagnosed with T2D.
  • * CGM-naïve
  • * HbA1c \>7.5% within 3 months of study commencement.
  • * Participants should also possess a smartphone, as this is needed in order to facilitate the collection of CGM data by the study team as well as homogenize CGM usage education.
  • * Known diagnosis of dysfunction/dementia or learning disabilities
  • * Not fluent in either English or Chinese
  • * Currently undergoing or planning to undergo diathermy or high-frequency heat treatments in whom CGM use may be contraindicated
  • * Inability to travel due to frailty or health reasons
  • * Lack of internet access
  • * Critically ill populations, including those on dialysis
  • * Vulnerable populations (prisoners and women who are pregnant or planning to be pregnant during the time of study)

Ages Eligible for Study

40 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Joslin Diabetes Center,

George King, MD, PRINCIPAL_INVESTIGATOR, Joslin Diabetes Center

Study Record Dates

2024-05-31